A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: James, L. P.; Kris, M. G.; Heelan, R. T.; Ng, K. K.; Chia, G. H.; Gomez, J. E.; Krug, L. M.; Moore, E.; Hawkins, M. J.; Rizvi, N. A.
Abstract Title: A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 690s
Language: English
ACCESSION: WOS:000455043704484
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.18087
Notes: Meeting Abstract: 18087 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jorge Gomez
    27 Gomez
  2. Kenneth K Ng
    58 Ng
  3. Lee M Krug
    178 Krug
  4. Leonard Philip James
    13 James
  5. Naiyer A Rizvi
    166 Rizvi
  6. Mark Kris
    872 Kris
  7. Robert T Heelan
    140 Heelan
  8. Erin Moore
    5 Moore